Literature DB >> 22009045

Kinetic measurements give new insights into lipid membrane permeabilization by α-synuclein oligomers.

Martin Stöckl1, Mireille M A E Claessens, Vinod Subramaniam.   

Abstract

Interactions of oligomeric aggregates of the intrinsically disordered protein α-synuclein with lipid membranes appear to play an important role in the development of Parkinson's disease. The permeabilization of cellular membranes by oligomers has been proposed to result in neuronal death. The detailed mechanisms by which α-synuclein oligomers permeabilize lipid bilayers remain unknown. Two different mechanisms are conceivable. Oligomers may either insert into membranes forming pores through which small molecules can cross the membrane or their interaction with the membrane may disorder the lipid packing, giving rise to membrane defects. Here we show, using kinetic leakage measurements, that α-synuclein oligomer induced impairment of membrane integrity is not limited to the formation of permanent membrane spanning pores. Fast membrane permeabilization could be observed in a fraction of the large unilamellar vesicles. We have also observed, for the first time, that α-synuclein oligomers cause an enhanced lipid flip-flop. In neuronal cells, most of the α-synuclein is not expected to be present in an oligomeric form, but as monomers. In our in vitro experiments, we find that membrane bound monomeric α-synuclein can only delay the onset of oligomer-induced membrane permeabilization, implying that α-synuclein monomers cannot counteract oligomer toxicity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22009045     DOI: 10.1039/c1mb05293d

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  10 in total

1.  Amyloids of alpha-synuclein affect the structure and dynamics of supported lipid bilayers.

Authors:  Aditya Iyer; Nils O Petersen; Mireille M A E Claessens; Vinod Subramaniam
Journal:  Biophys J       Date:  2014-06-17       Impact factor: 4.033

2.  Dopamine Transporter Activity Is Modulated by α-Synuclein.

Authors:  Brittany Butler; Kaustuv Saha; Tanu Rana; Jonas P Becker; Danielle Sambo; Paran Davari; J Shawn Goodwin; Habibeh Khoshbouei
Journal:  J Biol Chem       Date:  2015-10-06       Impact factor: 5.157

Review 3.  α-Synuclein oligomers: an amyloid pore? Insights into mechanisms of α-synuclein oligomer-lipid interactions.

Authors:  Martin T Stöckl; Niels Zijlstra; Vinod Subramaniam
Journal:  Mol Neurobiol       Date:  2012-09-06       Impact factor: 5.590

Review 4.  Seeking a mechanism for the toxicity of oligomeric α-synuclein.

Authors:  Hazel L Roberts; David R Brown
Journal:  Biomolecules       Date:  2015-03-25

Review 5.  New Perspectives on Roles of Alpha-Synuclein in Parkinson's Disease.

Authors:  Guoxin Zhang; Yun Xia; Fang Wan; Kai Ma; Xingfang Guo; Liang Kou; Sijia Yin; Chao Han; Ling Liu; Jinsha Huang; Nian Xiong; Tao Wang
Journal:  Front Aging Neurosci       Date:  2018-11-22       Impact factor: 5.750

6.  Freezing and piercing of in vitro asymmetric plasma membrane by α-synuclein.

Authors:  Paul Heo; Frederic Pincet
Journal:  Commun Biol       Date:  2020-03-31

Review 7.  Impact of Fatty Acid-Binding Proteins in α-Synuclein-Induced Mitochondrial Injury in Synucleinopathy.

Authors:  An Cheng; Wenbin Jia; Ichiro Kawahata; Kohji Fukunaga
Journal:  Biomedicines       Date:  2021-05-17

8.  Modelling Ser129 phosphorylation inhibits membrane binding of pore-forming alpha-synuclein oligomers.

Authors:  Georg Sebastian Nübling; Johannes Levin; Benedikt Bader; Stefan Lorenzl; Andreas Hillmer; Tobias Högen; Frits Kamp; Armin Giese
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

9.  Structural characteristics and membrane interactions of tandem α-synuclein oligomers.

Authors:  Chunhua Dong; Marion Hoffmann; Xi Li; Meijing Wang; Craig R Garen; Nils O Petersen; Michael T Woodside
Journal:  Sci Rep       Date:  2018-04-30       Impact factor: 4.379

10.  A nanobody-based fluorescent reporter reveals human α-synuclein in the cell cytosol.

Authors:  Fitnat Buket Basmanav; Felipe Opazo; Christoph Gerdes; Natalia Waal; Thomas Offner; Eugenio F Fornasiero; Nora Wender; Hannes Verbarg; Ivan Manzini; Claudia Trenkwalder; Brit Mollenhauer; Timo Strohäker; Markus Zweckstetter; Stefan Becker; Silvio O Rizzoli
Journal:  Nat Commun       Date:  2020-06-01       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.